Home >
Access the latest news, business developments, company updates, industry trends, events and more.
The Yale School of Medicine Section of Cardiovascular Medicine and the Section of Rheumatology, Allergy, and Immunology offer a Cardio-Rheumatology Program to provide personalized cardiovascular risk assessment...
The economic impact on the State of Connecticut from its fifteen non-profit independent colleges and universities is $16.5 billion annually, according to a just completed study...
The newhavenbiz annual Power 25 list features individuals based in the Greater New Haven region who hold significant influence within their organizations and the broader business community....
View this email in your browser March 2, 2023 Alexion Pharmaceuticals is committed to working with the patient community and health care stakeholders worldwide to address...
CYduct Diagnostics recently won a prestigious grant award for their work within breast cancer risk assessment. The grant, generously awarded by the Sharon D. Lund Foundation,...
Guilford-based Hyperfine reports it has secured FDA approval of a software update for its portable MRI device that will boost its image quality and accuracy. With the...
New Haven’s Biohaven has earned FDA “Fast Track” designation for its drug to treat muscle loss in spinal muscular atrophy patients. Biohaven’s drug, taldefgrobep alfa, is scheduled...
Lumendi reports that it has received FDA 510(k) clearance for DiLumen EZ¹, a single-use, disposable endotherapy device for endoscopic mucosal resections (EMR) and difficult colonoscopies. The new,...
Cybrexa Therapeutics has reported the appointments of Laurie Kenvin as Vice President of Clinical Operations and Nick Saccomano, Ph.D., to the Company’s Scientific Advisory Board (SAB). “We...